Previous 10 | Next 10 |
United Therapeutics Corporation ( UTHR ) is in an unstoppable downtrend that started in March. Since reporting fourth-quarter results on Feb. 28, selling accelerated in May when the company posted its first-quarter results for 2019. After revenues fell and losses mounted, should investor...
IsoRay ( ISR +3.2% ) initiated with Buy rating and $1 (138% upside) price target at Dawson James. More news on: IsoRay, Inc., United Therapeutics Corporation, Dr. Reddy's Laboratories Limited, Healthcare stocks news, Stocks on the move, , Read more ...
The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts ...
The following slide deck was published by United Therapeutics Corporation in conjunction with this Read more ...
Liquidia Technologies (NASDAQ: LQDT ) updates investors on its Phase 3 clinical trial, INSPIRE , evaluating lead candidate LIQ861 in patients with pulmonary arterial hypertension (PAH). More news on: Liquidity Services, Inc., United Therapeutics Corporation, Healthcare stocks news, ...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , June 5, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond , Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company'...
MannKind ( MNKD ) announced today that Afrezza has received approval from ANVISA . The long-awaited approval is now in the books, and investors are trying to determine exactly how big this news is. The reaction from the market has been muted thus far, and likely for good reason. The press rel...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , May 28, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond , Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company's bus...
MannKind ( MNKD ) has its annual meeting on deck for May 14, 2019. While shareholders speculate about whether or not the company will break some news, the share price is down to $1.20. That share price could be a great entry point for active traders, as it rests at the low end of a trading ran...
ElectroCore (NASDAQ: ECOR ) initiated with Outperform rating and $19 (222% upside) at Noble Capital. More news on: electroCore, Inc., Sarepta Therapeutics, Inc., Flexion Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
United Therapeutics Corporation Company Name:
UTHR Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation Website:
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
2024-07-11 06:30:06 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for UTHR on July 11, 2024 04:53AM ET. The previous analyst recommendation was Overweight. UTHR was trading at $329.25 at issue of the analyst recommendation. The overall analyst consensus : ...
Over 100,000 patients in the United States have IPF, with two approved therapies available that only slow the course of disease progression Top line data expected in the second half of 2025 United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announ...